StockMarketWire.com - Liberum Capital today initiates coverage of Sensyne Health Plc Ord 10p [LON:SENS] with a buy investment rating and price target of 260p.

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk